The FDA has proposed a new rule that would seek to eliminate the adequate provision guidance in pharma DTC ads.
Remember that ad? Neither do we. Today, memorability is the new performance advantage for brands. Recently, marketing leaders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results